Former UCI president Hein Verbruggen has questioned Lance Armstrong's credibility after the American rider implicated the Dutchman in covering up doping at the 1999 Tour de France.
"Since when do people believe Lance Armstrong?" Verbruggen wrote in a text message to NOS television network in the Netherlands. "Since he told Oprah Winfrey he had never `sorted out' anything with the UCI? Or since he (for money!) makes films and gives interviews in which he apparently has to serve up juicy details?"
The Dutch official has not replied to messages from The Associated Press since Armstrong's allegations were published on Monday by Britain's Daily Mail.
Armstrong claimed Verbruggen insisted "we've got to come up with something" to explain the American's positive tests for a banned corticosteroid.
A backdated prescription for a saddle sores cream was accepted, allowing Armstrong to continue racing and win his first Tour, which revived cycling after doping scandals wrecked the 1998 race.
"His story is illogical because it was not about a positive/punishable act according to the anti-doping authority involved," wrote Verbruggen, adding that cycling's governing body did not have lead responsibility for anti-doping at the race 14 years ago.
"That authority was not the UCI but the French ministry. From accusations a year ago about large-scale complicity of the UCI in doping by Lance Armstrong and his team, we're now back to a cortisone case from 1999 that was not even handled by the UCI," said the former president, who stepped down in 2005 after Armstrong's seventh straight Tour victory.
Verbruggen, the UCI honorary president and IOC honorary member, is a likely target witness for an independent commission panel which the UCI is creating to investigate claims of collusion to protect Armstrong from scrutiny.
The UCI and World Anti-Doping Agency said in Johannesburg last week that the panel could begin work early next year.
Armstrong is expected to be the star witness and has suggested he wants a reduction in his lifetime ban imposed last year by the U.S. Anti-Doping Agency.
